New FDA BIMO Slides are out!

The new Bioresearch Monitoring Metrics for 2014

The inspectional data cover all aspects of FDA’s BIMO program (i.e., clinical investigators, IRBs, sponsors, bioequivalence, and good laboratory practices) for all Centers, as applicable. These data were provided by the individual Centers and may differ from other inspection data available on FDA’s website, as different criteria and/or methods for compiling the information may have been used. Also provided, at the first link, is a glossary of acronyms.

Read more online
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /